Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Hsp90 inhibitor XL888
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
XL888 with Vemurafenib for Patients with Unresectable BRAF Mutated Stage III/IV Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MCC #17013, NCI-2015-01692, NCT01657591
Start Over